Advertising & Promotional Labeling Questions and Answers
The FDA updated its Questions and Answers documentation regarding advertising and promotional labeling specifically for biological products.
Manufacturers of biological products, regulatory affairs specialists, and marketing compliance departments involved in the promotion of CBER-regulated products.
These clarifications likely refine CBER's interpretation of existing promotional regulations. Regulatory teams may need to review their internal submission workflows and promotional review committee (PRC) standards to ensure that advertising materials remain consistent with these specific FDA responses, potentially reducing the risk of receiving untitled or warning letters related to misbranding.
Regulatory teams should audit current promotional materials against this updated FAQ to ensure compliance with CBER expectations and verify that submission procedures for Form FDA 2253 align with the latest provided clarifications.
Advertising & Promotional Labeling Questions and Answers
Open in openFDA / FDA.gov